ALZINOVA
Alzinova AB is Swedish biotechnology enterprise engaged in the discovery and development of therapeutics for the treatment of Alzheimer’s disease. The company was founded in 2011 by the inventors of the AβCC peptide™ technology (patent pending) and MIVAC Development AB in close collaboration with the holding company at the University of Gothenburg in Sweden, GU Ventures AB. The proprietary AβCC peptide™ technology provides the company with long-term R&D capabilities towards several ends... , including the discovery and development of novel therapeutics, research tools and services that enhance productivity within Alzheimer’s disease research. Alzinova is exploiting the unique properties of this non-fibrillogenic technology to develop therapeutics and diagnostics otherwise unavailable when using fibrillogenic peptides. The company focuses on development of a unique highly specific oligomer-directed vaccine (ALZ-101), as well as on the development of diagnostics based on a monoclonal antibody (ALZ-201). Both products are specifically directed towards the form of oligomeric Aβ that damages brain synapses.
ALZINOVA
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2011-01-01
Address:
Gothenburg, Vastra Gotaland, Sweden
Country:
Sweden
Website Url:
http://www.alzinova.com
Total Employee:
1+
Status:
Active
Contact:
+46 70 428 26 56
Email Addresses:
[email protected]
Total Funding:
50 K EUR
Technology used in webpage:
Google Maps Amazon CrUX Dataset Amazon Virginia Region CrUX Top 10m Webflow Hosting
Similar Organizations
Angios
Angios is a biotechnology company, specializing in vascular research to provide solutions for diabetic retinopathy.
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Fore Biotherapeutics
We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Spyder Institute
Spyder Institute specializes in biotechnology R&D, offering peptide chemistry software and synthesizers.
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Alzinova
Official Site Inspections
http://www.alzinova.com Semrush global rank: 2.17 M Semrush visits lastest month: 9.25 K
- Host name: mkmedia-srv1.oderland.com
- IP address: 91.201.60.190
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "Alzinova"
Investors - Alzinova
Mar 7, 2025 Alzinova AB is a company specializing in the treatment of Alzheimer’s disease – one of our major health scourges, without effective treatment options. Latest press releases …See details»
Alzinova - Crunchbase Company Profile & Funding
Alzinova is exploiting the unique properties of this non-fibrillogenic technology to develop therapeutics and diagnostics otherwise unavailable when using fibrillogenic peptides. The …See details»
Alzinova Team - Alzinova
Anders is one of Alzinova’s co-founders and was also CEO of the Company during a transitional period. He has extensive experience in protein research with an emphasis on protein stability …See details»
Alzinova AB (publ) (ALZ.ST) - Yahoo Finance
See the company profile for Alzinova AB (publ) (ALZ.ST) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Alzinova - Funding, Financials, Valuation & Investors - Crunchbase
Alzinova operates as a biotechnology company engaged in drug discovery research for Alzheimer’s disease. New. Resources. ... Experience the new Crunchbase, powered by AI . …See details»
Alzinova - app.biopharmiq.com
About: Alzinova AB is a Swedish clinical-stage biopharma company developing treatments for Alzheimer’s disease by specifically targeting neurotoxic amyloid beta oligomers. The lead …See details»
Alzinova Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 Alzinova has 5 employees at their 1 location and kr270 k in annual revenue in FY 2023. See insights on Alzinova including office locations, competitors, revenue, financials, …See details»
Alzinova Company Profile 2025: Stock Performance & Earnings
Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is engaged in the …See details»
Our Story - Alzinova
The Alzinova Story. Alzinova AB is a clinical-stage biopharma company dedicated to developing both active and passive immunotherapies to treat Alzheimer’s disease. The beginnings. The …See details»
Alzinova AB (publ) (STO: ALZ) Company Profile & Overview - Stock …
Dec 30, 2024 Alzinova AB (publ), a biopharmaceutical company, develops immunotherapies treatment for Alzheimer’s disease in Sweden. Its lead product candidate is ALZ-101, an active …See details»
Alzinova - VentureRadar
Similar Companies: Hefei KS-V Peptide Biological Technology Co., Ltd. Unknown Privately Held Hefei KS-V peptide biological technology Co.,Ltd. is a high-tech enterprise focusing on peptide …See details»
Kirsten Harting Steps Down from Position of CMO of Alzinova AB
Jan 28, 2025 Alzinova AB (publ) announced that the Company's CMO is stepping down from her role after mutual agreement. The basis is a strategic decision to appoint a CMO in place at the …See details»
Alzinova Annual Report 2020
Alzinova is an innovative Swedish biopharma company specialized in the development of disease-modifying treatments for Alzheimer’s disease. Our goal is to enable patients to live an …See details»
Alzinova announces new positive safety review of its Phase 1b …
Sep 7, 2022 Alzinova AB is a Swedish clinical-stage biopharma company developing treatments for Alzheimer's disease by specifically targeting neurotoxic amyloid beta oligomers.See details»
Alzinova AB (publ) (ALZ.ST) - Yahoo Finance
Find the latest Alzinova AB (publ) (ALZ.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Alzinova - All patients in the extension part of the phase 1b
Apr 4, 2024 Alzinova AB (publ) (ticker: ALZ) can today announce that all patients participating in the extension part (part B) of the phase 1b study with the vaccine candidate ALZ-101 against …See details»
Board and Management - Alzinova
Anders is one of Alzinova’s co-founders and was also CEO of the Company during a transitional period. He has extensive experience in protein research with an emphasis on neurotoxic …See details»
Alzinova AB (Alzinova AB) - 药物管线_专利_临床试验_投融营收_最 …
了解Alzinova AB (Alzinova AB)公司的药物管线，治疗领域，技术平台，以及它的1项临床试, 6篇新闻，疾病领域:神经系统疾病，技术 ...See details»
News Archive - Alzinova
Oct 11, 2024 Alzinova at Redeye Neurology Event 2024. Tord Labuda, our CEO, presented at Redeye Neurology Event in Stockholm on October 23rd. Read more. 2024-10-23. Interview …See details»